Parsortix Cancer Diagnostics
Biomarkers are the future
Professor Dive, from the Cancer Research UK Paterson Institute for Cancer Research, talks about her research into biomarkers.
How it works
The Parsortix patented cell separation device can be used, on a reproducible basis, to isolate and capture very small numbers of cancer cells from whole blood...
read more
Commercial opportunity
Use of Parsortix's separation device to capture CTCs in cancer patient blood has an immediate market application for research purposes...
read more
Share Price
46.50p
Chg: 0.00p
Chg: (0.00%)
19 May 2012
ANGLE is quoted
on AIM (AGL)